When every second counts…
Instant Access to Overdose Medication
The CounterAct Cap is a novel nasal delivery system. The cap snaps directly on top of the prescription bottle and can contain rescue medication, such as Naloxone to be administered nasally in the event of an opioid overdose.
The CounterAct Cap is US patented
CounterAct is seeking drug development partners to advance this novel technology to save lives and mitigate the Opioid Overdose Epidemic.
People die each day from opioid-related drug overdose³
People misuse prescription opioids annually²
People died from opioid overdoses in 2020⁴
People had an opioid use disorder in 2019⁶
Economic Burden of prescription opioid misuse in the United States¹
Deaths attributed to overdose on commonly prescribed opioids in 2017²
Deaths attributed to overdose on synthetic opioids other than methadone in 2019⁵
Adolescents started to misuse prescription pain medications in 2017
A person is more likely to die from an accidental opioid overdose than from a motor vehicle crash.⁷
Re-Imagining Opioid Overdose Treatment
CounterAct has developed a US patented, Nasal Delivery Device that snaps on top of any bottle of prescription medicine. Underneath the outer cap is a nasal delivery system consisting of a stowed nasal nozzle that can be extended and inserted into a nostril in the event of an opioid overdose. With minimal pressure, the spring-loaded trigger can be pushed and the rescue medication can be nasally administered.
Health Human Services 5 Point Strategy to Combat the Opioid Overdose Epidemic
- Better Data by strengthening public health surveillance
- Better Pain Management
- Improving access to treatment, prevention and recovery services
- Increasing the availability of overdose-reversing drugs
- Supporting cutting-edge research
CounterAct Completes Human Factors Engineering/Usability Engineering (HFE/UE) Formative Study with Positive Results
CounterAct’s combination rescue medication platform device completed a Human Factors Engineering/Usability Engineering (HFE/UE) formative study. The purpose of the study was to support the design and development of the CounterAct System and served to identify use...
CounterAct Nasal Device User Preference Study
With nearly 255 people dying in the United States every day from opioid overdoses, the Opioid Overdose Epidemic has showed no signs of slowing (1). In 2017, The United States Health and Human Services (HHS) developed a 5 Point Strategy to address the opioid epidemic....
Make it stick – Drink and Drugs News
Despite all the good work that’s been done over the last couple of decades to fight the battle for naloxone and tackle the associated stigma, one key fact remains. As Judith Yates told DDN last month, ‘You need to have it with you’ (DDN, June, page 15). A commuter...
Naloxone coprescription laws may lead to more than 7-fold increase in dispensing
Legally mandating naloxone coprescriptions for patients at high risk for opioid overdose was tied to a 7.75-fold increase in dispensed naloxone prescriptions, according to study results published in JAMA Network Open. The findings suggest that legal mandates for...
Sources: 1 National Institute on Drug Abuse, 2 “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.2, 2 hhs.gov, 3 A Time of Crisis for the Opioid Epidemic in the USA, volume 398, Issue 102977, p277., 4 Centers for Disease Control gov, 5 drugabuse.gov, 6 samhsa.gov, 7 4 National Safety Council, January 2019